SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-000473
Filing Date
2021-01-04
Accepted
2021-01-04 20:27:45
Documents
2
Period of Report
2021-01-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm211461d7_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm211461d7_3seq1.xml 3 2819
2 POWER OF ATTORNEY tm211461d7_ex-24.htm EX-24 8463
  Complete submission text file 0001104659-21-000473.txt   12641
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Issuer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERONA PHARMA PLC 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address
Ullman Anders (Reporting) CIK: 0001836816 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38067 | Film No.: 21503617